Sensus Healthcare, Inc. Investors: Company Investigated by the Portnoy Law Firm

Core Insights - Sensus Healthcare, Inc. is under investigation for possible securities fraud, with a potential class action being considered for investors who suffered losses [1][2] - The company reported a GAAP earnings-per-share loss of $0.06 for Q2 2025, missing analyst estimates by $0.09, and revenue of $7.3 million, which is a 20.7% decline year-over-year [3] - Following the financial results announcement, Sensus stock price dropped by $1.89, approximately 35.3%, closing at $3.46 per share [4] Financial Performance - Sensus reported a revenue decline of $2 million compared to estimates, primarily due to reduced units sold to a large customer, although there was some growth in recurring revenue from Fair Deal Agreements [3] - The earnings miss and revenue drop have raised concerns among investors, prompting legal investigations [1][3] Legal Actions - The Portnoy Law Firm is actively encouraging affected investors to reach out for a complimentary case evaluation regarding their legal rights and options for recovering losses [2][5] - The firm has a history of recovering over $5.5 billion for investors affected by corporate wrongdoing [5]